Iovance Biotherapeutics Inc (NASDAQ:IOVA)
| 47.61 Delayed Data As of Jan 22 |  -0.04 / -0.08%Today’s Change | 18.70 Today|||52-Week Range 54.21 | +2.61% Year-to-Date |
Institutional investors purchased a net $3.5 million shares of IOVA during the quarter ended June 2019 and now own 101.05% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
| Mutual fund holders | 56.06% |
| Other institutional | 45.00% |
| Individual stakeholders | 0.64% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 12/31/2020 | ARK INVESTMENT MANAGEMENT LLC Bought 7.4 Million shares of Iovance Biotherapeutics I... |
| 12/31/2020 | CREDIT SUISSE ASSET MANAGEMENT (... Bought 138.9 Thousand shares of Iovance Biotherapeutics I... |
| 11/30/2020 | MEDICAL STRATEGY GMBH Bought 27.8 Thousand shares of Iovance Biotherapeutics I... |
Top 10 Owners of Iovance Biotherapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 10.43% | 15,297,822 | 709,818,941 | +7,394,514 | +93.56% |
| The Vanguard Group, Inc. | 7.89% | 11,578,678 | 537,250,659 | -446,813 | -3.72% |
| Perceptive Advisors LLC | 6.88% | 10,085,632 | 467,973,325 | -1,723,862 | -14.60% |
| Avoro Capital Advisor LLC | 6.50% | 9,536,039 | 442,472,210 | -825,000 | -7.96% |
| Franklin Advisers, Inc. | 5.65% | 8,283,853 | 384,370,779 | +1,355,911 | +19.57% |
| BlackRock Fund Advisors | 4.79% | 7,024,112 | 325,918,797 | -354,249 | -4.80% |
| T. Rowe Price Associates, Inc. (I... | 4.72% | 6,929,214 | 321,515,530 | -343,216 | -4.72% |
| OrbiMed Advisors LLC | 4.53% | 6,645,100 | 308,332,640 | 0 | 0.00% |
| Farallon Capital Management LLC | 4.06% | 5,955,000 | 276,312,000 | -582,500 | -8.91% |
| Great Point Partners LLC | 2.64% | 3,876,600 | 179,874,240 | +151,624 | +4.07% |
Top 10 Mutual Funds Holding Iovance Biotherapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| ARK Innovation ETF | 6.05% | 8,869,425 | 411,541,320 | +39,481 | +0.45% |
| ARK Genomic Revolution ETF | 4.21% | 6,168,462 | 286,216,637 | +92,768 | +1.53% |
| Vanguard Total Stock Market Index... | 2.55% | 3,740,022 | 173,537,021 | +10,210 | +0.27% |
| Hartford Mid Cap Fund | 2.20% | 3,232,380 | 149,982,432 | +1,028,066 | +46.64% |
| Vanguard Small Cap Index Fund | 2.13% | 3,129,198 | 145,194,787 | +21,583 | +0.69% |
| T Rowe Price Health Sciences Fund | 1.71% | 2,509,660 | 116,448,224 | +100,991 | +4.19% |
| T Rowe Price New Horizons Fund | 1.68% | 2,463,356 | 114,299,718 | +159,500 | +6.92% |
| Nikko AM Global Umbrella Fund - A... | 1.37% | 2,009,695 | 93,249,848 | +2,009,695 | -- |
| Franklin DynaTech Fund | 1.36% | 2,000,000 | 92,800,000 | 0 | 0.00% |
| FTIF SICAV - Biotechnology Discov... | 1.32% | 1,939,154 | 89,976,746 | +58,800 | +3.13% |